Current Opinion in Allergy and Clinical Immunology was launched in 2001. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of allergy and clinical immunology are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Editors and Section Editors for this issue.
Dr Mark Ballow received his MD from the University of Chicago Pritzker School of Medicine, USA. After a pediatric residency at Yale-New Haven Hospital, he completed an immunology fellowship at the University of Minnesota Hospitals. He was the chief of clinical and experimental immunology at Walter Reed Army Medical Center. He was then appointed as chief of the division of clinical immunology in the Department of Pediatrics at the University of Connecticut, USA from 1975 to 1988, and became chief of the division of allergy/clinical immunology and pediatric rheumatology, and program director of the allergy/immunology fellowship program at The Women and Children's Hospital of Buffalo, State University of New York at Buffalo, USA in 1988.
Dr Ballow is certified by the American Board of Pediatrics, American Board of Allergy & Immunology (ABAI), and in Clinical Laboratory Immunology. He was on the Board of Directors of the ABAI from 1992 – 1998. He has served on four editorial boards including the Journal of Allergy and Clinical Immunology (1984 – 1989;1995 – 2000), and is an Ad Hoc reviewer for a number of pediatric, allergy and immunology journals.
Dr Ballow has served as an ad hoc member of several NIH study sections, and was a member of the committee that published the first Allergy and Immunology Medical Knowledge Self Assessment Program (MK-SAP), and was a member of the new 3rd edition AI-MK-SAP. Dr Ballow is a Fellow of the American Academy of Asthma, Allergy and Immunology, and has served on the Board of Directors of the Academy (1996 – 1999), and has chaired the A/I Training Program Directors, Basic Clinical immunology Interest Section, and the Post-graduate Education Program. Dr Ballow is a member of the Clinical Immunology Society, the Buffalo Allergy Society, the Society for Pediatric Research, and the American Pediatric Society. He also serves on the Blood Product Advisory Committee of the FDA. He is President-elect of the American Academy of Asthma, Allergy and Immunology, and will become President in February, 2010.
Dr Ballow's major clinical interests include inner city asthma, chronic sinusitis, clinical immunology, and the uses and mechanisms of action of Intravenous Immune Globulin (IGIV). His research interests include the immunology of the newborn infant and the immunoregulatory effects of Vitamin A and retinoic acid.
G. Walter Canonica
Professor Giorgio Walter Canonica is Chairman of the Dept of Medical Specialties (University Hospital S. Martino Genoa) and Director of the Allergy & Respiratory Diseases Clinic, Genoa University Italy a Galen Centre of Excellence. Professor Canonica first specialised in pulmonary diseases after having received his medical degree from the University of Genoa. He then specialised in Allergy and Clinical Immunology at Florence University, Italy. He subsequently conducted clinical immunology and allergology research in several European universities and institutes, in addition to two years at the Medical University of South Carolina, USA. Since returning to the University of Genoa in 1995, Professor Canonica has held a number of academic positions including Director of the Speciality School of Allergy and Clinical Immunology, Director of the Specialty School of Pulmonary Diseases and Chairman of the Allergy & Respiratory Diseases Clinic.
He is Board Member of ARIA (Allergic Rhinitis and its impact Asthma) guidelines.
Professor Canonica's research interests include examination of the molecular events and interactions between immunocompetent cells, inflammatory cells and epithelial cells in allergic inflammation and airway remodelling. He is particularly involved in new strategies in the treatment of allergic disease, including biological response modifiers, such as specific immunotherapy (with a special focus on SLIT – sublingual immunotherapy). Professor Canonica has published extensively in international journals and acts as a referee of many immunology journals. He is also Editor in Chief of Current Opinion in Allergy and Clinical Immunology. In addition, Professor Canonica is a member of a number of societies, and recently served 6 years as Secretary General and President Elect of the World Allergy Organisation (WAO), he was president of WAO 2008/09. He is also 1st Vice President of Interasma.
Professor Dr Ruby Pawankar did her medical education from the Armed Forces Medical College (AFMC) in Pune, India and her specialization in ENT from the B J Medical College in Pune, India. She was invited to Japan on an International Fellowship of the Japanese Association of University Women, where she did her doctorate in ENT and Allergology and Immunology. She is now an Associate Professor at the Department of ENT, Nippon Medical School, Tokyo, Japan. She also serves as a Guest Professor at the Department of Pediatrics, Showa University School of Medicine, Tokyo, Japan and the Department of Otolaryngology, Kyung Hee University School of Medicine, Seoul, Korea.
Dr Pawankar is a Member of the Board of Directors of the World Allergy Organization (WAO), an Executive Committee Member of the WHO Rhinitis Guidelines Initiative (ARIA) and Chairperson of its Asia-Pacific Affiliate. She is the Vice-Chair of the Rhinitis Committee of the American Academy of Allergy, Asthma and Immunology and is a Committee Member of several Consensus documents on Rhinosinusitis and Allergic Rhinitis. She is the Founding President of the International Symposium on Allergic Rhinitis (ISBAAR) and is a Committee Member/Faculty of several International/National Congresses in the field of Rhinology, Allergy and Asthma.
Dr Pawankar is a member of several prestigious academic organizations like the ‘Collegium International Allergolicum’, has received several prestigious academic awards and grants, has published more than 65 book chapters, more than 300 original papers and reviews and more than six books. She is an Associate Editor/Editorial Board Member of several prestigious national/ international journals like Current Opinion in Allergy and Clinical Immunology, WAO Journal, Int Archives Allergy and Immunology, Clinical Experimental Allergy, Am J Rhinology.
Dr David P. Skoner is Director of Allergy, Asthma, and Immunology in the Department of Pediatrics of Allegheny General Hospital in Pittsburgh, Pennsylvania. He is also Professor of Pediatrics at the Drexel University College of Medicine in Philadelphia, Pennsylvania, USA and Clinical Professor of Pediatrics, West Virginia University School of Medicine, USA. Previously, he was Associate Professor of Pediatrics and Otolaryngology at the University of Pittsburgh, School of Medicine in Pittsburgh, Pennsylvania, USA, and has served as the Chief of the Section of Allergy/Immunology and Director of the Allergy and Immunology Training Program at the Children's Hospital of Pittsburgh.
Dr Skoner received his BS degree from Juniata College in Huntingdon, Pennsylvania, USA and his MD degree from Temple University in Philadelphia, Pennsylvania, USA. He served his residency in general pediatrics at Children's Hospital in Cincinnati, Ohio, and he completed his fellowship in allergy/immunology at Children's Hospital in Pittsburgh.
His current research interests include the relationships between respiratory viruses, asthma, immunity, and stress; the relationship between viral and allergen-induced nasal inflammation and middle ear disease; and the efficacy and safety (HPA axis function and growth in children) of inhaled and intranasal steroids. Dr. Skoner has received NIH funding and written more than 100 articles and given more than 200 presentations on respiratory disease. His articles and abstracts have been published in many leading journals, including Pediatrics, Journal of Allergy and Clinical Immunology, Pediatric Research, American Journal of Respiratory and Critical Care Medicine, JAMA, and American Review of Respiratory Disease. Dr Skoner serves on the editorial advisory boards of the journals Current Allergy and Asthma Reports, and Current Opinion in Allergy and Clinical Immunology, and previously served on the editorial board of the American Journal of Rhinology. He is a Fellow of the American Academy of Pediatrics and a member of the Society of Pediatric Research, the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma & Immunology, the Association for Research in Otolaryngology, and the American Pediatric Society. He has been recognized as one of America's “Top Doctors” (Pediatric Allergy & Immunology, Castle Connolly Medical Ltd.) from 2001 to 2010 and as one of the Most Influential Doctors by USA TODAY. He was recently invited to join the Best Pharmaceuticals for Children Act (BPCA) Pediatric Asthma Therapeutics Group convened by the National Institute of Child Health and Human Development.
Dr Skoner co-founded the Nemacolin Asthma Conference, now in its fifth year. He also founded and is the President of For Your Good Health, a Pennsylvania non-profit corporation that brings together asthma stakeholders in the development and implementation of state-of the-art programs to educate children with asthma and their caregivers about the disease and its management. The aim of these programs is to reduce asthma's impact on patients, caregivers, the community, and the healthcare system by helping the patients to lead near-normal lives.
Stephen T. Holgate
Applying basic science to the clinical interface in allergy and asthma has been the guiding principle of Stephen Holgate's career. This has involved him in environmental and genetic epidemiology, physiology, cell and molecular biology of disease processes as they occur in humans. An AAAAI member since 1986 and Fellow from 2001, Professor Holgate has been active in the field of allergy and immunology both in the United Kingdom and overseas as well as contributing to the Academy. He was President of the British Society of Allergy and Clinical Immunology (BSACI) from 1990–1993, British Thoracic Society in 2006 and the Robert Cooke Memorial Lecturer in 1995 and 2000. He has been an active contributor to the CIA since 1990 and is currently its Secretary General and Board member of the World Allergy Organisation.
Professor Holgate is a member of the Infection, Inflammation and Immunity Division in the School of Medicine, University of Southampton at Southampton General Hospital, UK and since 1987 has held a Medical Research Council (MRC) Clinical Professorship. He received his undergraduate medical training at Charing Cross Hospital, London and specialised in respiratory medicine and allergy. He holds Fellowships from the Royal Colleges of Physicians, Pathologists, Institute of Biology, Institute of Biomedical Science and Academy of Medical Sciences. He is Chairman of the UK Medical Research Councils Population and Systems Medicine Board and member of the MRC Strategy Board and its Pharmaceuticals Panel. He is Chairman of the UK Science Council's Science in Health Group, and member of Council of the Academy of Medical Sciences. He was founder Chairman of the UK Department of Health Committee on the Medical Effects of Air Pollutions (COMEAP) for 10 years, and, as a current member of COMEAP, chairs its subcommittee on Air Quality Standards and has been appointed as Chairman of the UK Government Advisory Committee on Hazardous Substances.
Professor Holgate was Co-Editor of Clinical and Experimental Allergy for 25 years till 2008 and has served on the editorial board of the Journal of Allergy and Clinical Immunology. He has edited several textbooks on allergy “Allergy” now in its 3rd edition and is one of the Co-Editors of Allergy: Principles and Practice. He has published over 900 papers in peer reviewed journals. His work has been recognised with a Scientific Achievement Award of the IAACI in 1994, the Rhône-Poulenc Rorer World Health Award in 1995, the King Faisal International Prize in Medicine in 1999 and Doctorates Hon Causa at University of Ferrara, Italy and Jagellonian University, Kraków, Poland in 1997 and 1999 respectively. He received the American Academy of Allergy, Asthma and Immunology Honorary Fellow Award in 2001 and the European Academy of Allergy and Clinical Immunology Paul Ehrlich award for research in 2008.
Dr Grant is a native of Florida and received his undergraduate degree from Harvard University, USA in biochemical sciences. After attending Duke Medical School, USA, he did a residency in internal medicine at New York Hospital – Cornell Medical Center in New York City. He did a fellowship in immunology with Leroy Hood at the National Institutes of Health and an allergy-immunology clinical fellowship at Johns Hopkins University with Phillip Norman and Lawrence Lichtenstein. In 1973, he established the first basic and clinical research program in allergy in Texas at the University of Texas Medical Branch in Galveston, USA. Presently he is Professor in the Departments of Medicine and Microbiology-Immunology and training Program Director in allergy-immunology at that institution. He has served as division director and vice chair for research within the Department of Internal Medicine.
Dr Grant has been an active member of the American Academy of Allergy, Asthma and Immunology for over three decades. His contributions to this organization include chairing the Training Program Directors' Committee, Mechanisms of Allergy Interest Section, Postgraduate Education Committee, Scientific Workshops and Exhibits Committee, and Immunotherapy Committee. He served on the Editorial Board of the Journal of Current Opinion in Allergy and Clinical Immunology. Currently he chairs the in-training Examination Committee.
Dr Grant served as president of the Texas Allergy Asthma and Immunology Society and a director of the American Board of Allergy and Immunology. He chaired the Pulmonary-Allergy Drugs Advisory Committee of the Food and Drugs Administration. Currently he is on the Residency Review Committee for Allergy and Immunology.
Dr Grant's research interests have included mechanisms of cellular activation especially the role of chemokines and novel therapies for allergic disorders. He was a visiting professor at the National Heart and Lung Institute with Professor Barry Kay in 1994. He has authored over 180 publications and chapters and 150 presentations at national and international meetings.
© 2011 Lippincott Williams & Wilkins, Inc.